Parathyroid hormone (PTH) and fibroblast growth factor-23 (FGF23) levels rise in the early stages of CKD and increase phosphate excretion to maintain normal serum phosphate concentrations [4–6]. This evidence concerns the gene PTH and chronic kidney disease.